ArticleArthritis research & therapy2019
Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis.
Yan Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled ittrialcites it